$1.94
+0.02 (+1.04%)
GENK News15 articles
Kyndryl Deploys Policy-as-Code to Rein In Autonomous AI Agents
Kyndryl has introduced a policy-as-code system to enforce business rules on autonomous AI agents in regulated environments, responding to growing governance concerns.
Generac Shares Stabilize After Earnings Surge, Focus Shifts to Data Center Expansion
Generac's stock steadied in premarket trading following a sharp post-earnings rally, as investors assess the company's strategic pivot toward data center power systems and a new share repurchase plan.
IRS Direct Deposit Errors Could Delay 2026 Tax Refunds, Agency Warns
The IRS cautions that incorrect bank details may freeze refunds this filing season, urging taxpayers to verify information and use electronic tools for faster processing.
Dollar General Gains on Raised Price Target Amid Economic Data Focus
Dollar General shares advanced after Gordon Haskett increased its price target to $180, while investors monitor inflation data and upcoming earnings.
Legal & General Shares Dip Amid AI Anxiety in Insurance Sector
Legal & General shares fell 0.5% in early London trading, tracking broader insurer declines as AI disruption fears resurface. Investors await full-year results on March 11.
AI Sector Sees Divergence: Datadog Soars on Earnings, Alphabet Issues Debt for Infrastructure
Datadog shares surged over 14% after strong quarterly results driven by AI demand, while Alphabet sold $20 billion in bonds to fund AI infrastructure spending. Cisco and Cadence gained on new chip developments.
Salesforce Trims Workforce Amid AI Strategy Shift, Agentforce Unit Impacted
Salesforce has reduced its headcount by under 1,000 employees in early February, affecting marketing, product management, and its Agentforce AI division, according to a report.
Amgen Shares Slide on FDA Setback and Enbrel Weakness, Pressuring Dow
Amgen stock fell nearly 2% Monday, pressured by an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% quarterly drop in Enbrel sales. The decline weighed on the price-weighted Dow Jones Industrial Average.
Intuit Shares Decline Amid Divergent Analyst Views on AI Impact
Intuit stock fell 1.3% to $438.01 Monday, underperforming the software sector, as TD Cowen cut its price target citing AI concerns while Jefferies maintained a bullish stance.
Solana's SOL Dips to $83 Amid Divergent $20-$250 Price Outlooks
Solana's SOL token fell over 4% to near $83, with futures liquidations rising. Analysts present a wide 2026 range, from $20 on legal risks to $250 if stablecoin adoption accelerates.
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.
Siemens Gains on Major Copenhagen Rail Contract Ahead of Key Earnings Week
Siemens shares advanced 2.45% following a €3 billion automated train contract win in Copenhagen. Investors now focus on upcoming Q1 results and a proposed €5.35 dividend.
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.
Siemens Gains on €3 Billion Copenhagen Automated Train Contract Ahead of Quarterly Results
Siemens shares rose 2.45% to €250.50 after its Mobility unit, with partner Stadler, secured a €3 billion framework contract for 226 driverless trains in Copenhagen. The company reports Q1 earnings and holds its AGM on February 12.
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.